Pulsed field ablation market seen reaching $2.37 billion by 2030

The Business Research Company says the pulsed field ablation market is expanding as atrial fibrillation rises and hospitals adopt newer catheter-based treatments. The market is projected to grow from $0.8 billion in 2025 to $2.37 billion by 2030, with North America leading and Asia-Pacific expected to grow fastest.

Why it matters: - Pulsed field ablation is gaining traction as a minimally invasive option for treating cardiac arrhythmias, especially atrial fibrillation. - The market growth reflects rising demand for safer and more precise alternatives to traditional ablation methods. - A larger patient pool, driven by aging populations and more atrial fibrillation cases, is expanding the commercial opportunity.

What happened: - The Business Research Company released a pulsed field ablation market report on Aug. 25, 2026. - The report estimates the market will grow from $0.8 billion in 2025 to $0.99 billion in 2026. - The same report forecasts the market will reach $2.37 billion by 2030. - The report puts the 2025-2026 growth rate at 23.8% and the 2026-2030 CAGR at 24.4%. - The report includes regional coverage for Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis.

The details: - Pulsed field ablation uses short bursts of high-voltage electrical pulses to target heart tissue responsible for arrhythmias. - The method is designed to spare surrounding healthy tissue and reduce complications tied to conventional ablation. - The technology is increasingly used to treat atrial fibrillation. - Growth in the market is linked to more atrial fibrillation diagnoses, broader use of catheter-based ablation, advances in cardiac mapping systems and higher cardiovascular awareness. - The report points to aging global demographics, better healthcare infrastructure in emerging economies, artificial intelligence in ablation procedures, demand for minimally invasive treatments and hybrid ablation energy sources as major growth drivers beyond 2026. - The report highlights patient-specific ablation planning, improved safety profiles, advanced imaging and mapping integration, and faster adoption in electrophysiology laboratories as key trends. - North America held the largest regional share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - A September 2024 report in the American Journal of Managed Care said about 10.5 million U.S. adults, or around 5% of the population, have atrial fibrillation. - Download a free sample of the report. - View the full market report.

Between the lines: - The report frames pulsed field ablation as part of a broader shift toward less invasive cardiac procedures. - The emphasis on AI, imaging integration and patient-specific planning suggests the next phase of competition may center on precision and workflow efficiency, not just procedure volume. - The regional outlook points to a mature North American market and a faster-expanding Asia-Pacific opportunity.

What's next: - The market is expected to keep expanding as cardiovascular disease rates climb and healthcare systems adopt newer ablation platforms. - Commercial momentum will likely depend on whether manufacturers can improve safety, speed and procedural accuracy while scaling adoption in electrophysiology labs. - The report says future growth will also be shaped by hybrid technologies and more advanced treatment planning tools.

The bottom line: - Pulsed field ablation is moving from an emerging technique to a fast-growing cardiac treatment category, with strong demand tied to atrial fibrillation and a multi-billion-dollar market outlook.